Geron Corp. Stock
€4.23
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Geron
sharewise wants to provide you with the best news and tools for Geron, so we directly link to the best financial data sources.
Financials
News
Geron (GERN) Q2 2024 Earnings Call Transcript
Is Geron Stock a Buy Following Its First New Drug Approval?
Shares of Geron (NASDAQ: GERN) finished the week ended June 7 about 32% higher. The market was reacting to news the company's investors had been waiting to hear for decades.
On June 6, the U.S. Food
Geron (GERN) Q1 2024 Earnings Call Transcript
Geron Corporation: FDA Approval Fuels Stock Price Surge
The recent FDA approval of RYTELO™ (imetelstat) has propelled Geron Corporation (NASDAQ: GERN) into the spotlight, sparking a surge in Geron’s stock price and attracting heightened attention